Skip to content
Companies

CardioMech AS

Catheter-delivered chord repair for leaky mitral valves

Raised to date

$17.6M

of $17.6M offered across 1 Form D filing

Investors
58
Last filed
Apr 21, 2025

About

CardioMech AS is a Norwegian medical device company dedicated to innovating minimally invasive solutions for structural heart disease, particularly degenerative mitral regurgitation (DMR). With a focus on transforming patient care, the company aims to provide effective alternatives to traditional surgery for this common and serious heart condition.

CardioMech AS is distinguished by its development of catheter-based devices that simplify the repair of mitral valve dysfunction without the need for open-heart surgery.

Funding

  • DebtFiled Apr 21, 2025Form D
    $17.6M/ $17.6M

Product

CardioMech Device

Medical Device

The CardioMech device functions as an artificial chord for transcatheter mitral valve chordal repair. It is designed to be delivered through a minimally invasive, transfemoral, transseptal approach, allowing for ease of insertion and minimal recovery time.

  • Minimally invasive procedure
  • Transfemoral access
  • Transseptal navigation

Built for

Patients with degenerative mitral regurgitation and healthcare facilities specializing in cardiac treatments

People on file